摘要
目的观察并分析沙丁胺醇以及普米克令舒治疗小儿哮喘急性发作的效果以及应用价值。方法将2012年7月—2014年8月在该院接受治疗的100例哮喘急性发作的患儿作为此次研究的对象,按照随机分配的方法将患儿分为实验组(n=50)和对照组(n=50),给予对照组患儿常规治疗,在对照组的基础上,再给予实验组患儿沙丁胺醇以及普米克令舒进行治疗,观察两组患儿的临床治疗效果以及临床症状消失时间。结果实验组患儿的治疗总有效率明显高于对照组患儿(P<0.05),实验组患儿气促、咳嗽、憋喘以及啰音消退时间明显少于对照组患儿(P<0.05)。结论应用沙丁胺醇以及普米克令舒治疗小儿哮喘急性发作,其疗效确切,值得大力推广应用。
Objective Observe and analyze the effect of albuterol and Pulmicort treatment of pediatric asthma exacerbations and Value. Methods The children from July 2013 to August 2014 in our hospital treated 100 cases of acute asthma as the object of this research, according to the random assignment of patients were divided into experimental group(n = 50) and control group(n =50), administered to the control group of children with conventional treatment, on the basis of the control group, the experimental group of children and then give albuterol and Pulmicort treatment, clinical treatment and the clinical symptoms of the two groups of children disappearing time. Results Treatment of patients in the experimental group was significantly higher in patients with total efficiency(P<0.05), the experimental group were shortness of breath, cough, dyspnea and crackles subside hold time was less than the control group patients(P<0.05). Conclusion Application of albuterol and Pulmicort treatment of pediatric asthma exacerbations, its efficacy, worth promoting applications.
出处
《中外医疗》
2015年第25期149-150,共2页
China & Foreign Medical Treatment